• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Sigma Computing, Snowflake partner to launch solution on Healthcare and Life Sciences Data Cloud

Article

Sigma extends access to powerful no-code cloudscale data analytics for industry-compliant data cloud so healthcare professionals and researchers can find faster answers to critical questions.

Sigma Computing announced today that it has partnered with Snowflake, the Data Cloud company, to launch a seamless integration and out-of-the-box experience for joint customers on the Snowflake Healthcare and Life Sciences Data Cloud.

The Snowflake Healthcare and Life Sciences Data Cloud offers healthcare companies a single, integrated, and cross-cloud data platform that eliminates technical and institutional data silos so that they can securely centralize, integrate, and exchange critical and sensitive data at scale. The new partnership will allow joint customers to remain compliant when using Sigma’s data exploration platform, which is purpose-built for the business user.

According to the companies, by leveraging the Sigma and Snowflake partnership, organizations can place the power of their data directly in the hands of business users, enabling them to explore billions of data lines and freely drill down while applying their subject matter expertise for better decisions and outcomes.

“Sigma was built from the ground up to support Data Cloud users, and we’re proud to work directly with Snowflake to ensure that healthcare companies can draw greater value from their data while being able to trust that compliance is baked in,” Rob Woollen, CTO/Co-Founder at Sigma Computing, said in the news release. “The Healthcare & Life Sciences Data Cloud is an excellent step in streamlining cloud data adoption for this industry. In combination with tools like ours, the ecosystem will fuel faster innovations with greater data insights to deliver better patient care and drive smarter business decisions.”

Patrick Kovalik, Industry Principal Healthcare/Life Sciences at Snowflake, Sigma's solutions align with his company’s own objectives to provide healthcare and life sciences companies with a simple, intuitive enterprise data platform that can deliver business insights across huge datasets with speed.

“Healthcare data has no size limit and Sigma gives a user the power of a familiar analytics interface that can interpret tens of millions of rows within a single dashboard,” he said as a news release.

Leading Healthcare and Life Sciences organizations can leverage Sigma to take advantage of the growing quantities of data on Snowflake’s platform through a fast, simple interface that allows for faster decisions backed by data.

All organizations on the Snowflake Healthcare and Life Sciences Data Cloud can begin using Sigma with a simple one-time deployment that takes minutes. Sigma’s spreadsheet-like interface dramatically simplifies complex analytics by empowering users to build sophisticated pivot tables, quickly create and iterate dashboards, and aggregate or free-drill into billions of records.

Related Videos
 John Bladen, MBBS, BSc, MRCS, PGCert, PhD, FRCOphth, consultant ophthalmologist and oculoplastic surgeon, King's College Hospital NHS Foundation Trust, London, UK, speaks with Ophthalmology Times Europe's® Caroline Richards
rande, CFP, and John S. Grande, CFP, of Grande Financial Services, continue their discussion with Ophthalmology Times®' Sheryl Stevenson
What keeps you up at night?
S.K. Steven Houston III, MD, discusses retina innovations in use in his practice, including the NGENUITY 1.4 upgrade from Alcon
Caesar Luo, MD, shares his key take-aways on diabetic retinopathy progression in anti-VEGF versus FA implant
© 2024 MJH Life Sciences

All rights reserved.